Use of prior information to stabilize a population data analysis
- PMID: 12795242
- DOI: 10.1023/a:1022972420004
Use of prior information to stabilize a population data analysis
Abstract
When modeling new data with a complex population pharmacokinetic/pharmacodynamic model, there may not be sufficient information to obtain estimates of all parameters. In this case information from previous studies can also be used to help stabilize estimation. Using simulated data, we explored three different ways to do this. (i) Some parameter values were fixed to estimates obtained from earlier data. (ii) The earlier data were combined with the current data. (iii) The objective function based on the current data was augmented by a penalty function expressing summary information obtained from the earlier data. This last method is similar to the use of a Bayesian prior. It may be particularly useful when either the combined data set of method (ii) is very large and leads to large computation times or when the early data are not readily available. With this method, two different types of penalty functions were used. With our examples, the three methods all resulted in stabilized estimation. Methods (ii) and (iii) gave similar results for parameter and standard error estimation, especially with respect to fixed effects parameters. For hypothesis testing, results obtained with method (i) are very problematic. There are also problems with the results obtained with method (iii), but they are much less severe, and when the design for the earlier data is known, they can be corrected by using a computer-intensive simulation test procedure.
Similar articles
-
Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.Clin Pharmacokinet. 2006;45(4):365-83. doi: 10.2165/00003088-200645040-00003. Clin Pharmacokinet. 2006. PMID: 16584284
-
Analyzing multi-response data using forcing functions.J Pharmacokinet Pharmacodyn. 2005 Apr;32(2):283-305. doi: 10.1007/s10928-005-0065-8. Epub 2005 Nov 7. J Pharmacokinet Pharmacodyn. 2005. PMID: 16283535
-
Assessing convergence of Markov chain Monte Carlo simulations in hierarchical Bayesian models for population pharmacokinetics.Ann Biomed Eng. 2004 Sep;32(9):1300-13. doi: 10.1114/b:abme.0000039363.94089.08. Ann Biomed Eng. 2004. PMID: 15493516
-
Bayesian parameter estimation and population pharmacokinetics.Clin Pharmacokinet. 1992 Jun;22(6):447-67. doi: 10.2165/00003088-199222060-00004. Clin Pharmacokinet. 1992. PMID: 1587057 Review.
-
A survey of population analysis methods and software for complex pharmacokinetic and pharmacodynamic models with examples.AAPS J. 2007 Mar 2;9(1):E60-83. doi: 10.1208/aapsj0901007. AAPS J. 2007. PMID: 17408237 Free PMC article. Review.
Cited by
-
Current Approaches and Techniques in Physiologically Based Pharmacokinetic (PBPK) Modelling of Nanomaterials.Nanomaterials (Basel). 2020 Jun 29;10(7):1267. doi: 10.3390/nano10071267. Nanomaterials (Basel). 2020. PMID: 32610468 Free PMC article. Review.
-
Can We Improve Stavudine's Safety Profile in Children? Pharmacokinetics of Intracellular Stavudine Triphosphate with Reduced Dosing.Antimicrob Agents Chemother. 2018 Oct 24;62(11):e00761-18. doi: 10.1128/AAC.00761-18. Print 2018 Nov. Antimicrob Agents Chemother. 2018. PMID: 30104267 Free PMC article.
-
Development of a dosage strategy in patients receiving enoxaparin by continuous intravenous infusion using modelling and simulation.Br J Clin Pharmacol. 2006 Aug;62(2):165-76. doi: 10.1111/j.1365-2125.2006.02650.x. Br J Clin Pharmacol. 2006. PMID: 16842391 Free PMC article.
-
Pharmacokinetic and pharmacodynamic modelling for renal function dependent urinary glucose excretion effect of ipragliflozin, a selective sodium-glucose cotransporter 2 inhibitor, both in healthy subjects and patients with type 2 diabetes mellitus.Br J Clin Pharmacol. 2019 Aug;85(8):1808-1819. doi: 10.1111/bcp.13972. Epub 2019 Jun 20. Br J Clin Pharmacol. 2019. PMID: 31026084 Free PMC article. Clinical Trial.
-
A continued learning approach for model-informed precision dosing: Updating models in clinical practice.CPT Pharmacometrics Syst Pharmacol. 2022 Feb;11(2):185-198. doi: 10.1002/psp4.12745. Epub 2021 Dec 27. CPT Pharmacometrics Syst Pharmacol. 2022. PMID: 34779144 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources